Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma

被引:0
作者
Tao, Haisu [1 ,2 ]
Zhang, Yuxin [1 ,2 ]
Yuan, Tong [1 ,2 ]
Li, Jiang [1 ,2 ]
Liu, Junjie [1 ,2 ]
Xiong, Yixiao [1 ,2 ]
Zhu, Jinghan [1 ,2 ]
Huang, Zhiyong [1 ,2 ]
Wang, Ping [3 ]
Liang, Huifang [1 ,2 ]
Zhang, Erlei [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Hepat Surg Ctr, Wuhan, Peoples R China
[2] Hubei Key Lab Hepatopancreato Biliary Dis, Wuhan, Peoples R China
[3] Guangzhou Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Guangzhou, Peoples R China
来源
AGING-US | 2022年 / 14卷 / 03期
基金
中国国家自然科学基金;
关键词
HCC; EMT; prognostic signature; LINC01116; immune; MESENCHYMAL TRANSITION; METASTASIS; EZH2;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Epithelial-mesenchymal transition (EMT) plays a critical role in the recurrence and metastasis of hepatocellular carcinoma (HCC). Some long noncoding (lnc)RNAs are involved in this process through the regulation of EMT-related transcription factors. Methods: In this study, we established a novel EMT-related lncRNA signature in HCC and identified hub lncRNAs that can serve as potential therapeutic targets. Differentially expressed lncRNAs were identified by screening HCC patient data from The Cancer Genome Atlas, and a correlation analysis was performed to identify those associated with EMT. The EMT-related lncRNA signature was established by univariate, least absolute shrinkage and selection operator, and multivariate Cox regression analyses. After verifying the prognostic accuracy of the signature, its relationships to immune cell infiltration and immune checkpoint targets were explored. LINC01116 was identified as a hub lncRNA and its role in HCC was investigated in vitro and in vivo. YResults: A 5-lncRNA signature was developed for HCC and its prognostic accuracy was assessed by survival, time-dependent receiver operating characteristic curve, clinical correlation, and Cox regression analyses. The correlation analysis showed that the lncRNA signature was closely related to immune cell infiltration and 10 immune checkpoint targets and also predicted the prognosis of HCC patients with high accuracy. In vitro and in vivo experiments revealed that LINC01116 stimulated cell proliferation, cell cycle progression, and tumor metastasis. We also found that LINC01116 was closely related to immune regulation. Conclusions: These results demonstrate that LINC01116 is an immune-related oncogene that is associated with both EMT and immune regulation in HCC. Moreover, the EMT-related lncRNA signature that includes LINC01116 can guide risk stratification and clinical decision-making in HCC management.
引用
收藏
页码:1473 / 1491
页数:19
相关论文
共 50 条
  • [21] Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma
    Yin, Ji
    Li, Xiaohui
    Lv, Caifeng
    He, Xian
    Luo, Xiaoqin
    Li, Sen
    Hu, Wenjian
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [22] An immune-related lncRNA pairs signature to identify the prognosis and predict the immune landscape of laryngeal squamous cell carcinoma
    Qian, Lvsheng
    Ni, Tingting
    Fei, Bing
    Sun, Hui
    Ni, Haosheng
    BMC CANCER, 2022, 22 (01)
  • [23] An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma
    Chen, Yue
    Luo, Tian-Qi
    Xu, Si-Si
    Chen, Chun-Yan
    Sun, Ying
    Lin, Li
    Mao, Yan-Ping
    CANCER MEDICINE, 2021, 10 (07): : 2268 - 2285
  • [24] An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients
    Pengfei Xia
    Qing Li
    Guanlin Wu
    Yimin Huang
    Cellular and Molecular Neurobiology, 2021, 41 : 365 - 375
  • [25] Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients With Hepatocellular Carcinoma
    Zhou, Pengcheng
    Lu, Yuhua
    Zhang, Yewei
    Wang, Lei
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [26] Identification and Verification of a Glycolysis-Related lncRNA Prognostic Signature for Hepatocellular Carcinoma
    Qiu, Fakai
    Yu, Guozheng
    Li, Mei
    Li, Zhubin
    Zhang, Qinyang
    Mu, Xudong
    Cheng, Yuan
    Zhai, Pengtao
    Liu, Qunyi
    HORMONE AND METABOLIC RESEARCH, 2024, 56 (11) : 827 - 834
  • [27] An Immune-Related lncRNA Signature to Predict Survival In Glioma Patients
    Xia, Pengfei
    Li, Qing
    Wu, Guanlin
    Huang, Yimin
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2021, 41 (02) : 365 - 375
  • [28] Identification of the EMT-Related Genes Signature for Predicting Occurrence and Progression in Thyroid Cancer
    Li, Qiang
    Jiang, Sheng
    Feng, Tienan
    Zhu, Tengteng
    Qian, Biyun
    ONCOTARGETS AND THERAPY, 2021, 14 : 3119 - 3131
  • [29] Identification of immune-related biomarkers in adrenocortical carcinoma Immune-related biomarkers for ACC
    Peng, Yun
    Song, Yuxuan
    Ding, Jin
    Li, Nan
    Zhang, Zheyu
    Wang, Haitao
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 88
  • [30] The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma
    Ghionescu, Alina-Veronica
    Sorop, Andrei
    Dima, Simona Olimpia
    FRONTIERS IN PHARMACOLOGY, 2023, 14